Frovocimab Biosimilar (PCSK9 Reference Antibody)
Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody (mAb) that neutralizes PCSK9. Frovocimab inhibits PCSK9 binding to LDL receptor (LDLR) while permitting the normal proteolytic cleavage of the bound intact PCSK9.
Product Specifications
Target
Frovocimab Biosimilar (Anti-PCSK9 Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Metabolism Research
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Lsx04182-500gEcoli 500 µg (E. coli)
Recombinant Legionella Pneumophila rpmI Protein (aa 1-66) (strain Paris)
Sign In for Pricing
View Details 
LS165215-100ug 100 µg
FAM171B (NM_177454) Human Over-expression Lysate
Sign In for Pricing
View Details abx270867-01 25 Tests
Chemokine C-C-Motif Receptor 1 (CCR1) Antibody (PE)
Sign In for Pricing
View Details